{site_meta && site_meta.display_name} Logo

NewMediaWire

NewMediaWire distributes press releases on behalf of hundreds of publicly traded companies, as well as private corporations, non-profits and other public sector organizations. Founded and staffed by industry veterans, we offer a full complement of services including specialized delivery to financial sites and posting of photos and multimedia content. In addition, NewMediawire offers international and specialized services such as IR websites and industry specific distribution.

RSS Feed for NewMediaWire

Humanoid Robotics: Schaeffler Wins Hermes Award for Innovative Actuator Platform

April 20, 2026 Schaeffler receives prestigious Hermes Award for its scalable actuator platform for humanoids Platform comprises highly integrated actuators specially developed for use in humanoid robot joints Accolade underscores Schaeffler’s key role as a component supplier in the humanoid robotics segment HANOVER and HERZOGENAURACH, GERMANY - April 20, 2026 (NEWMEDIAWIRE) - Motion Technology Company Schaeffler has received the globally renowned Hermes Award for its highly integrated actuator platform for humanoids. An independent jury chaired by Prof.


Humanoid Robotics: Schaeffler Wins Hermes Award for Innovative Actuator Platform

April 20, 2026 Schaeffler receives prestigious Hermes Award for its scalable actuator platform for humanoids Platform comprises highly integrated actuators specially developed for use in humanoid robot joints Accolade underscores Schaeffler’s key role as a component supplier in the humanoid robotics segment HANOVER and HERZOGENAURACH, GERMANY - April 20, 2026 (NEWMEDIAWIRE) - Motion Technology Company Schaeffler has received the globally renowned Hermes Award for its highly integrated actuator platform for humanoids. An independent jury chaired by Prof.


Humanoid Robotics: Schaeffler Wins Hermes Award for Innovative Actuator Platform

April 20, 2026 Schaeffler receives prestigious Hermes Award for its scalable actuator platform for humanoids Platform comprises highly integrated actuators specially developed for use in humanoid robot joints Accolade underscores Schaeffler’s key role as a component supplier in the humanoid robotics segment HANOVER and HERZOGENAURACH, GERMANY - April 20, 2026 (NEWMEDIAWIRE) - Motion Technology Company Schaeffler has received the globally renowned Hermes Award for its highly integrated actuator platform for humanoids. An independent jury chaired by Prof.


Formycon Invites to Conference Call on the Results of the Financial Year 2025 and Announces Participation in International Investor Conferences in the 2nd Quarter of 2026

April 20, 2026PLANEGG-MARTINSRIED, GERMANY - April 20, 2026 (NEWMEDIAWIRE) - Formycon AG (FSB: FYB, Prime Standard, "Formycon“) plans to publish its results of the financial year 2025 on April 22, 2026. The Management Board will discuss the company’s development, key financial figures, and provide an outlook for the 2026 fiscal year.


Beeline Holdings (BLNE) Expands Embedded Mortgage Strategy Through SRG Partnership

April 20, 2026LOS ANGELES, CA - April 20, 2026 (NEWMEDIAWIRE) - Beeline Holdings (NASDAQ: BLNE), a fast-growing digital mortgage platform offering a quicker and easier path to homeownership, is advancing its strategy to embed mortgage and title services directly into digital real estate platforms, with a newly announced partnership with Structured Real Estate Group (“SRG”). The agreement, detailed in a company press release, positions Beeline’s technology inside SRG’s AI-driven property ecosystem, allowing users to move from property selection to financing without leaving a single interface (https://ibn.


LIXTE Biotechnology Holdings (LIXT) Positions LB-100 as Novel Approach in Cancer Treatment Landscape

April 20, 2026LOS ANGELES, CA - April 20, 2026 (NEWMEDIAWIRE) - Boca Raton, Florida-based LIXTE Biotechnology Holdings (NASDAQ: LIXT) spent 2025 expanding its presence across multiple segments of oncology innovation. “The company is best known for its clinical-stage pharmaceutical pipeline built around LB-100, a first-in-class inhibitor of protein phosphatase 2A (‘PP2A’),” a recent article reads.


Why Cardio Diagnostics Holdings (CDIO) is 'One to Watch'

April 20, 2026LOS ANGELES, CA - April 20, 2026 (NEWMEDIAWIRE) - Artificial intelligence-powered cardiovascular medicine company Cardio Diagnostics Holdings (NASDAQ: CDIO) was featured in a recent article that discussed its focus on cardiovascular disease prevention, detection, and management. The publication reads, “The company’s approach is centered on advancing how cardiovascular disease is addressed by moving beyond traditional methods that rely on indirect or generalized indicators… At the core of its strategy is the integration of epigenetics, genetics, and artificial intelligence to generate insights from a patient’s molecular profile.


Soligenix (SNGX) Strengthens Pipeline as European Commission Grants SGX945 Orphan Status

April 20, 2026LOS ANGELES, CA - April 20, 2026 (NEWMEDIAWIRE) - Recognition from global regulatory authorities can serve as a powerful validation of a therapy’s potential, particularly in the rare disease space where development challenges are significant and patient needs are urgent. Soligenix (NASDAQ: SNGX) has secured that type of validation, as the European Commission granted orphan drug designation to its investigational therapy SGX945 for the treatment of Behçet’s disease, reinforcing both the promise of the therapy and the company’s broader development strategy.


Ocumetics Reports Improvement in Six Month First-in-Human Results Meaningful Improvements in Patient Quality of Life

April 20, 2026Key Highlights - Vision performance: Clinical outcomes exceed expectations, with all patients experiencing continuing vision improvements - Safety profile: Continues to meet expectations - Quality-of-life improvements: Anecdotally, all patients reported life changing results from lens implantations - Technology validation: Results reinforce the expected performance of Ocumetics’ inaugural accommodating intraocular lens - Momentum: Forward momentum continues, with lens design enhancements in manufacturing and testing phase - Webinar: April 22, 2026, 4:00 PM ET. Register at www.


tZERO Launches Regulated Private Marketplace for Web3 Secondaries

April 20, 2026New Platform Introduces Institutional Liquidity Solutions for Locked Tokens, SAFEs, SAFTs, and Private Equity in Crypto-Native Companies NEW YORK, NY - April 20, 2026 (NEWMEDIAWIRE) - tZERO Group, Inc. , a leading innovator in blockchain-powered multi-asset infrastructure, today announced the launch of its private marketplace for the secondary trading of private, illiquid Web3 assets.


Insurance Canopy Launches Drone Liability and Equipment Coverage for Creative Professionals and Small Businesses

April 20, 2026New Offering Gives Photographers and Creative Professionals a Clear Path to Protecting Drone Operations and Gear Key Highlights: Eliminates the need for separate standalone coverage, with drone liability and equipment coverage add-ons available Built for working professionals using drones in paid projects, aligning coverage with real-world business use Addresses common gaps in standard policies that exclude or limit aircraft and drone-related risks PLEASANT GROVE, UTAH - April 20, 2026 (NEWMEDIAWIRE) - Insurance Canopy, a national leader in small business and vendor insurance solutions, is pleased to announce an expansion of its Full Frame Insurance (FFI) program to include drone liability and drone equipment coverage. The addition is tailored for photographers, videographers, and other creative professionals who use drones as part of their work.


Affluence Corporation Enters Negotiations to Restructure Convertible Debt

April 20, 2026DENVER, CO - April 20, 2026 (NEWMEDIAWIRE) - Affluence Corporation (OTCID: AFFU), a diversified global technology company focused on Smart City, Industrial IoT, and security software solutions, today announced that it has entered negotiations with the holders of the majority of its outstanding convertible debt to restructure these obligations into long-term preferred equity instruments. These discussions represent the next and final phase of the Company’s broader balance sheet restructuring strategy, which has focused on eliminating legacy liabilities and potentially eliminating the impact of dilutive convertible instruments.


Martial Arts History Museum Offers Sneak Peek of New Armenian Section in Glendale

April 19, 2026GLENDALE, CA - April 19, 2026 (NEWMEDIAWIRE) - The Martial Arts History Museum is proud to invite the public to an exclusive first look at its newest addition, the Armenian section. Sponsored in part by US Armenia, this preview offers a unique lens into the heart of Armenian heritage, weaving together the profound connections between traditional dance, historical weaponry, and the storied legacy of Armenian wrestling.


Precision Oncology Is Shifting Toward Combination Strategies, Ultimately Changing How New Therapies Are Built

April 17, 2026LOS ANGELES, CA - April 17, 2026 (NEWMEDIAWIRE) - Cancer treatment is entering a phase where the question is no longer which single therapy works best, but how treatments can be combined to improve outcomes. Across oncology, resistance and relapse remain persistent challenges, and the industry’s response has been increasingly clear: multi-drug regimens targeting different biological pathways are delivering results that single agents cannot.


Soligenix (SNGX) Advances CTCL Research With Interim Analysis, Comparative Study Results

April 17, 2026LOS ANGELES, CA - April 17, 2026 (NEWMEDIAWIRE) - Advancing clinical research while generating positive data is a critical combination in biotechnology, particularly when addressing diseases with limited treatment options. Soligenix (NASDAQ: SNGX) is demonstrating that momentum as it provides both an encouraging clinical update from its phase 3 FLASH2 study and positive comparative clinical results for its HyBryte therapy, reinforcing the company’s focus on developing innovative treatments for serious conditions.